Another critical pathway implicated in pancreatic tumor progression is the EGFR signaling pathway, which regulates various aspects of tumor cell behavior and contributes to resistance to chemotherapy and chemoradiation. This evidence concerns the gene EGFR and pancreatic neoplasm.